Skip to content
Review

Molecular insights and therapeutic innovations in low-risk human papillomavirus-associated cutaneous wart

Sep 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 114 references
Medicine

TL;DR

Clinical management strategies for HPV associated warts are studied, including primary destructive treatment, immunotherapies, and novel adjunctive therapies with clinical evidence including photodynamic therapy, intralesional chemotherapeutics, and emerging HPV vaccination strategies.

View source

Similar papers

Review Open access Oct 2026

From HPV infection to cervical precancer: Molecular mechanisms, immune microenvironment and emerging technologies

In conclusion, incorporating genomics, transcriptomics, immunotherapy, and artificial intelligence will enable more personalized and effective interventions, ultimately reducing the global burden of cervical cancer.

Yu-Bing Zhou, Yun-Xiao Ge, Kang-Dong Liu et al. · 0 citations
Review Open access Oct 2026

Beta-Papillomaviruses in Cutaneous and Mucosal Carcinogenesis: Oncogenic Mechanisms, Host Cofactors, and Clinical Significance

Human papillomaviruses of the beta genus (beta-HPV) are ubiquitous components of the cutaneous virome, persistently colonizing the skin of immunocompetent individuals from early infancy. Unlike their alpha counterparts, which drive mucosal carcinogenesis through viral integration and sustained oncoprotein expression, b...

Sayma Vizcarra-Ramos, Jesús García-Gómez, W. Rojo-Contreras et al. · 0 citations
Review Open access Aug 2026

HUMAN PAPILLOMAVIRUS (HPV): CURRENT STRATEGIES FOR THE PREVENTION AND TREATMENT OF PRECANCEROUS LESIONS

Background: Human papillomavirus (HPV) infection is the primary etiology of cervical cancer and its immediate precursors, collectively known as cervical intraepithelial neoplasia (CIN). Although primary prevention via prophylactic vaccination and secondary screening have significantly reduced incidence, cervical cancer...

Wiktor Śliwiński, Jakub Mazur, M. Kosowski et al. · 0 citations
Review Sep 2026

NF-κB signaling in persistent high-risk cervical HPV infection: Clinical evidence, molecular mechanisms, and translational therapeutic opportunities.

Clinical evidence regarding NF-κB activation in persistent cervical high-risk HPV infection is synthesized and mechanistic insights from molecular studies are integrated to develop a translational framework for therapeutic intervention.

Maryam Mashhadi Abolghasem Shirazi · 0 citations
Review Open access Sep 2026

Advances in immunotherapy for HPV-associated malignancies: emerging strategies and clinical progress

Human papillomavirus (HPV) is the principal etiological factor in the majority of cervical, oropharyngeal, anal, and vulvar cancers. Persistent infection with high-risk HPV types promotes immune evasion, malignant transformation, and tumor progression. Currently licensed prophylactic HPV vaccines, based on L1 virus-lik...

A. Alsalloum, Alena P. Zakhareva, J. Lopatnikova et al. · 0 citations
2026

Current strategies for the diagnosis, treatment, and prevention of cervical lesions associated with human papillomavirus: microbiome, CRISPR technologies, and photodynamic therapy

Human papillomavirus (HPV) is a major factor in the etiology of cervical intraepithelial neoplasia (CIN) and cervical cancer, which ranks fourth worldwide in prevalence among cancers in women. The pathogenesis of HPV-associated lesions is based on the expression of E6 and E7 oncoproteins, which disrupt cell differentia...

Aida Gilyadova, Solomon O. Onozha Solomon O. Onozha, Elizaveta Kulikova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.